Clinical Trials Browser

Phase 3 × Uterine Cervical Neoplasms × Duration of Therapy × Clear all

NCT00092482 2017-03-22

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Phase 3 Completed

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT00517309 2017-03-22

FUTURE

Phase 3 Completed

Uterine Cervical Neoplasms, Condylomata Acuminata